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Chronic obstructive pulmonary disease (COPD) is a
lung disease associated with chronic systemic in-
flammatory syndrome [1]. COPD is often associat-
ed with comorbidities that need to be evaluated be-
cause they affect the severity of the disease. Anxiety
and depression are often observed in patients affect-
ed by COPD [2]. As pointed out by Tetikkurt and
colleagues in this issue of Multidisciplinary
Respiratory Medicine [3], COPD patients have to
carry an important psychological burden related to
their disease. In addition, in these patients, and due
to unknown mechanisms, anxiety and depression
increase the risk of re-hospitalization and increase
mortality [4-6]. It is somewhat surprising that the
degree of lung function impairment does not ex-
plain the level of anxiety and depression seen in
these patients. Indeed, in most of the previous stud-
ies no correlation was found between the psycho-
logical aspects of COPD and the forced expiratory
volume in 1 second (FEV1) value. Instead, anxiety or
depression have been shown to be correlated to the
presence of respiratory symptoms. Dyspnea and re-
duced exercise capacity are the predominant mech-
anisms leading to anxiety and depression symptoms
associated with COPD.
In the study by Tetikkurt and colleagues, the preva-
lence of these symptoms increased as the BODE in-
dex (a composite score of body mass, obstruction,
dyspnea and exercise capacity) increased. The au-
thors explain this finding arguing that dyspnea and
reduced exercise capacity were the predominant
mechanisms leading to the anxiety and depression
associated with COPD. Indeed, dyspnea and re-
duced exercise capacity correlated significantly
with the presence of the anxiety and depression
symptoms. They conclude that the BODE index is
superior to the Global Initiative for Obstructive
Lung Disease (GOLD) classification for explaining
anxiety and depression in COPD. 
Curiously, also bronchoalveolar lavage (BAL) cyto-
logic findings correlated significantly with the pres-
ence of the anxiety and depression symptoms.
Tetikkurt and colleagues explain this finding by rea-
soning that BAL abnormalities reflect the distal lung
damage, and as the lung damage gets worse dys -
pnea increases. Indeed, the correlation found be-
tween the severity of the atypical findings of BAL
cytology and the Modified Medical Research
Council (MMRC) index and the 6-minute walk dis-
tance (6MWD) suggests that dyspnea and the con-
sequent functional physical limitation may be relat-
ed to the severity of the peripheral lung damage
identified by BAL cytology. Tetikkurt and colleagues
may go a bit too far in suggesting BAL cytology as a
screening tool for COPD patients to determine the
presence of symptoms of anxiety or depression, or
as a noninvasive tool for identifying psychiatric co-
morbidities. However, the results are very interest-
ing and worth further investigating. 
In conclusion, anxiety and depression are common
symptoms in COPD. There is a clear association be-
tween dyspnea and anxiety or depression in COPD,
and these symptoms are correlated with and con-
tribute to the severity of the disease. Further studies
are needed to better understand the relationship be-
tween psychological abnormalities and the patho-
physiology of COPD. 
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